News, Analysis & Insights on Nutrition, Supplements, and Health
Special edition: Supplements for pets
As we saw on the human side, the market for pet supplements expanded in 2020 and this growth has been sustained, says Bill Bookout, president of the National Animal Supplement Council (NASC).
Swiss biotech company Evolva is launching a natural sugar blocker for food and drink applications. L-arabinose is also a reducing sugar, the company’s head of investor and corporate relations tells FoodNavigator.
British pharma company GlaxoSmithKline (GSK) are to pair up with Eligo Bioscience in a deal potentially worth €185m ($224m) that sees the firms target the microbiome to reduce the risk of developing acne.
Lonza is to sell off two European sites to NextPharma in a deal that gives the contract development and manufacturing firm facilities to work with lipid oral dosage forms for the nutrition and pharma markets.
FrieslandCampina Ingredients has identified the pursuit of health and wellbeing, personalised nutrition, convenience and sustainable authenticity as the four key trends that will shape the performance and active nutrition space in 2021.